Evidence map›Paper›PMID 39769252›Full record

Observational studyInternational journal of molecular sciences2024

Molecular Detection of Lymph Node Metastases with One-Step Nucleic Acid Amplification (OSNA) Pooling in Prostate Cancer: The POPCORN Study.

Mercè Cuadras, Maria E Semidey, Jacques Planas, Inés M de Torres, Lucas Regis, Ana Celma, Enrique Trilla, Santiago Ramón Y Cajal, Rafael A Medina, Belén Congregado and 19 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Mercè CuadrasUrology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.ORCID 0000-0003-4715-9230
Maria E SemideyPathology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Jacques PlanasUrology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Inés M de TorresPathology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Lucas RegisUrology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Ana CelmaUrology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Enrique TrillaUrology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Santiago Ramón Y CajalPathology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.ORCID 0000-0002-3867-1390
Rafael A MedinaUrology Department, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.ORCID 0000-0002-4514-4329
Belén CongregadoUrology Department, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
David MarcillaPathology Department, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Miguel A JapónPathology Department, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.ORCID 0000-0002-5980-5044
Miguel RamirezClínica Urosalud, 46021 Valencia, Spain.ORCID 0000-0001-6214-784X
Ana Calatrava-FonsPathology Department, Institut Valencià d'Oncologia, 46009 Valencia, Spain.
Asier LeivarUrology Department, Hospital Universitario La Paz, 28046 Madrid, Spain.
María B AlonsoUrology Department, Hospital Universitario La Paz, 28046 Madrid, Spain.
Eugenia GarcíaPathology Department, Hospital Universitario La Paz, 28046 Madrid, Spain.
Pilar González-PeramatoPathology Department, Hospital Universitario La Paz, 28046 Madrid, Spain.
Dario Vazquez-MartulUrology Department, Hospital Universitario A Coruña, 15006 A Coruña, Spain.ORCID 0000-0003-3060-1897
Ángel Concha-LópezPathology Department, Hospital Universitario A Coruña, 15006 A Coruña, Spain.
Venancio ChantadaUrology Department, Hospital Universitario A Coruña, 15006 A Coruña, Spain.
Francisco J QueipoPathology Department, Hospital Universitario A Coruña, 15006 A Coruña, Spain.ORCID 0000-0002-4173-6300
José L GagoUrology Department, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.ORCID 0009-0002-1639-8386
Cristina CarratoPathology Department, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Rafael J LuquePathology Department, Hospital Universitario de Jaén, 23007 Jaén, Spain.ORCID 0000-0002-9808-784X
Juan Moreno-JimenezUrology Department, Hospital Universitario de Jaén, 23007 Jaén, Spain.
Inmaculada Catalina-FernándezPathology Department, Hospital Universitario de Puerto Real, 11510 Cádiz, Spain.
Cristina LeónUrology Department, Hospital Universitario Puerta del Mar, 11510 Cádiz, Spain.
Juan MoroteUrology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.ORCID 0000-0002-2168-323X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pelvic lymph node dissection (PLND) is the most accurate procedure for lymph node (LN) staging in prostate cancer (PCa) patients. LN sectioning and hematoxylin and eosin (H&E) staining of at least one slice remains the gold standard for LN evaluation, potentially leading to misdetection of small metastatic focus. Entire LN analysis is possible with One-Step Nucleic Acid Amplification (OSNA) by detecting cytokeratin 19 (CK19) mRNA as a surrogate for LN invasion. This study aimed to compare postoperative performance of OSNA pooling with conventional H&E staining for pathological LN detection in PCa patients. POPCORN was an observational, prospective, and multicenter study of patients with PCa who underwent PLND. Dissected LNs were analyzed by both methods. This study included 2503 LNs from 131 patients, showing no statistically significant differences in pathological LN detection. Concordance between methods was high (93.9%), as were specificity (96.6%) and negative predictive value (96.6%) of OSNA pooling. The measure of agreement (Cohen's Kappa [κ]) was 0.70. Only eight (6.1%) discordances were observed, including four misdetections from each method. Results showed a high concordance between OSNA pooling and H&E staining, suggesting that OSNA pooling may be a good alternative to H&E staining to detect LN metastases in PCa patients.

Indexed as

Keratin-19Lymphatic MetastasisLymph NodesNucleic Acid Amplification TechniquesProstatic NeoplasmsAgedBiomarkers, TumorHumansLymph Node ExcisionMaleMiddle AgedProspective StudiesBiomarkers, TumorKeratin-19KRT19 protein, humancytokeratin 19hematoxylin and eosin staininglymph node metastasesOSNApelvic lymph node dissectionpoolingprostate cancer

Identifiers

PMID39769252
PMCPMC11679750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.